STAAR Surgical Reports Q1 EPS of $0.10, Returns to Profitability with $5.2M Net Income
STAA sits 99% above its 52-week low of $15.585.
Summary
STAAR Surgical reported Q1 2026 earnings per share of $0.10 and a net income of $5.206 million, marking a return to profitability. This positive Q1 performance contrasts sharply with the significant $80.4 million net loss reported for the full fiscal year 2025. The company also posted Q1 operating income of $7.979 million and a gross profit of $68.859 million with a strong gross margin of 73.6%. While the company recently proposed a highly dilutive 3.9 million share increase to its equity plan, these Q1 results provide a much-needed positive operational update, suggesting a potential turnaround from prior financial struggles. Traders will be watching if this profitability trend continues and how it impacts the company's capital structure.
At the time of this announcement, STAA was trading at $31.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $15.59 to $30.81. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.